IDH2 and central nervous system cancer: IDH-mutant gliomas exhibit reduced NK and CD8 + T-cell infiltration compared to IDH-wild gliomas and are resistant to innate cytotoxic immune mechanisms, indicating they are inherently capable of escaping immune surveillance [45].